Literature DB >> 25769928

Perturbed T cell IL-7 receptor signaling in chronic Chagas disease.

M Cecilia Albareda1, Damián Perez-Mazliah2, M Ailén Natale2, Melisa Castro-Eiro2, María G Alvarez3, Rodolfo Viotti3, Graciela Bertocchi3, Bruno Lococo3, Rick L Tarleton4, Susana A Laucella5.   

Abstract

We have previously demonstrated that immune responses in subjects with chronic Trypanosoma cruzi infection display features common to other persistent infections with signs of T cell exhaustion. Alterations in cytokine receptor signal transduction have emerged as one of the cell-intrinsic mechanisms of T cell exhaustion. In this study, we performed an analysis of the expression of IL-7R components (CD127 and CD132) on CD4(+) and CD8(+) T cells and evaluated IL-7-dependent signaling events in patients at different clinical stages of chronic chagasic heart disease. Subjects with no signs of cardiac disease showed a decrease in CD127(+)CD132(+) cells and a reciprocal gain of CD127(-)CD132(+) in CD8(+) and CD4(+) T cells compared with either patients exhibiting heart enlargement or uninfected controls. T. cruzi infection, in vitro, was able to stimulate the downregulation of CD127 and the upregulation of CD132 on T cells. IL-7-induced phosphorylation of STAT5 as well as Bcl-2 and CD25 expression were lower in T. cruzi-infected subjects compared with uninfected controls. The serum levels of IL-7 were also increased in chronic chagasic patients. The present study highlights perturbed IL-7/IL-7R T cell signaling through STAT5 as a potential mechanism of T cell exhaustion in chronic T. cruzi infection.
Copyright © 2015 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25769928      PMCID: PMC4391971          DOI: 10.4049/jimmunol.1402202

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  38 in total

Review 1.  Apoptosis and the homeostatic control of immune responses.

Authors:  David Hildeman; Trine Jorgensen; John Kappler; Philippa Marrack
Journal:  Curr Opin Immunol       Date:  2007-07-20       Impact factor: 7.486

Review 2.  Intrinsic and extrinsic control of effector T cell survival and memory T cell development.

Authors:  Timothy W Hand; Susan M Kaech
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

Review 3.  Regulation of memory T cells by γc cytokines.

Authors:  Lisa Colleen Osborne; Ninan Abraham
Journal:  Cytokine       Date:  2009-10-30       Impact factor: 3.861

Review 4.  Redefining chronic viral infection.

Authors:  Herbert W Virgin; E John Wherry; Rafi Ahmed
Journal:  Cell       Date:  2009-07-10       Impact factor: 41.582

5.  Assessment of CD8(+) T cell differentiation in Trypanosoma cruzi-infected children.

Authors:  María Cecilia Albareda; Gabriela Carina Olivera; Ana María De Rissio; Miriam Postan
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

6.  Absence of both IL-7 and IL-15 severely impairs the development of CD8 T cell response against Toxoplasma gondii.

Authors:  Rajarshi Bhadra; Hongbing Guan; Imtiaz A Khan
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

7.  Chagas disease: a Latin American health problem becoming a world health problem.

Authors:  Gabriel A Schmunis; Zaida E Yadon
Journal:  Acta Trop       Date:  2009-11-20       Impact factor: 3.112

8.  Chronic human infection with Trypanosoma cruzi drives CD4+ T cells to immune senescence.

Authors:  María Cecilia Albareda; Gabriela Carina Olivera; Susana A Laucella; María Gabriela Alvarez; Esteban Rodrigo Fernandez; Bruno Lococo; Rodolfo Viotti; Rick L Tarleton; Miriam Postan
Journal:  J Immunol       Date:  2009-08-19       Impact factor: 5.422

9.  Responsiveness of T cells to interleukin-7 is associated with higher CD4+ T cell counts in HIV-1-positive individuals with highly active antiretroviral therapy-induced viral load suppression.

Authors:  Jose F Camargo; Hemant Kulkarni; Brian K Agan; Alvaro A Gaitan; Lisa A Beachy; Sowmya Srinivas; Weijing He; Stephanie Anderson; Vincent C Marconi; Matthew J Dolan; Sunil K Ahuja
Journal:  J Infect Dis       Date:  2009-06-15       Impact factor: 5.226

10.  HLA Class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease.

Authors:  María G Alvarez; Miriam Postan; D Brent Weatherly; María C Albareda; John Sidney; Alessandro Sette; Carina Olivera; Alejandro H Armenti; Rick L Tarleton; Susana A Laucella
Journal:  PLoS Negl Trop Dis       Date:  2008-09-03
View more
  12 in total

1.  Defective Signaling in the JAK-STAT Pathway Tracks with Chronic Inflammation and Cardiovascular Risk in Aging Humans.

Authors:  Shai S Shen-Orr; David Furman; Brian A Kidd; Francois Hadad; Patricia Lovelace; Ying-Wen Huang; Yael Rosenberg-Hasson; Sally Mackey; Fatemeh A Gomari Grisar; Yishai Pickman; Holden T Maecker; Yueh-Hsiu Chien; Cornelia L Dekker; Joseph C Wu; Atul J Butte; Mark M Davis
Journal:  Cell Syst       Date:  2016-10-13       Impact factor: 10.304

Review 2.  Understanding CD8+ T Cell Immunity to Trypanosoma cruzi and How to Improve It.

Authors:  Eva V Acosta Rodríguez; Cintia L Araujo Furlan; Facundo Fiocca Vernengo; Carolina L Montes; Adriana Gruppi
Journal:  Trends Parasitol       Date:  2019-10-10

3.  Chronic Chagas' Disease: Targeting the Interleukin-2 Axis and Regulatory T Cells in a Condition for Which There Is No Treatment.

Authors:  Jose Mengel; Fabíola Cardillo; Lain Pontes-de-Carvalho
Journal:  Front Microbiol       Date:  2016-05-13       Impact factor: 5.640

4.  Trypanosoma cruzi-specific IFN-γ-producing cells in chronic Chagas disease associate with a functional IL-7/IL-7R axis.

Authors:  María A Natale; Gonzalo Cesar; María G Alvarez; Melisa D Castro Eiro; Bruno Lococo; Graciela Bertocchi; María C Albareda; Susana A Laucella
Journal:  PLoS Negl Trop Dis       Date:  2018-12-05

5.  Ex vivo characterization of Breg cells in patients with chronic Chagas disease.

Authors:  Magalí C Girard; Gonzalo R Acevedo; Micaela S Ossowski; Marisa Fernández; Yolanda Hernández; Raúl Chadi; Karina A Gómez
Journal:  Sci Rep       Date:  2021-03-09       Impact factor: 4.379

6.  Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell Responses.

Authors:  María G Alvarez; Graciela L Bertocchi; Gretchen Cooley; María C Albareda; Rodolfo Viotti; Damián E Perez-Mazliah; Bruno Lococo; Melisa Castro Eiro; Susana A Laucella; Rick L Tarleton
Journal:  PLoS Negl Trop Dis       Date:  2016-04-29

7.  The Significance of Discordant Serology in Chagas Disease: Enhanced T-Cell Immunity to Trypanosoma cruzi in Serodiscordant Subjects.

Authors:  Melisa D Castro Eiro; María G Alvarez; Gretchen Cooley; Rodolfo J Viotti; Graciela L Bertocchi; Bruno Lococo; María C Albareda; Ana M De Rissio; María A Natale; Cecilia Parodi; Rick L Tarleton; Susana A Laucella
Journal:  Front Immunol       Date:  2017-09-15       Impact factor: 7.561

8.  Distinct Treatment Outcomes of Antiparasitic Therapy in Trypanosoma cruzi-Infected Children Is Associated With Early Changes in Cytokines, Chemokines, and T-Cell Phenotypes.

Authors:  María C Albareda; María A Natale; Ana M De Rissio; Marisa Fernandez; Alicia Serjan; María G Alvarez; Gretchen Cooley; Huifeng Shen; Rodolfo Viotti; Jacqueline Bua; Melisa D Castro Eiro; Myriam Nuñez; Laura E Fichera; Bruno Lococo; Karenina Scollo; Rick L Tarleton; Susana A Laucella
Journal:  Front Immunol       Date:  2018-09-13       Impact factor: 7.561

Review 9.  Chronic Infections: A Possible Scenario for Autophagy and Senescence Cross-Talk.

Authors:  Milton O Aguilera; Laura R Delgui; Patricia S Romano; María I Colombo
Journal:  Cells       Date:  2018-10-10       Impact factor: 6.600

10.  IL-7 induces sCD127 release and mCD127 downregulation in human CD8+ T cells by distinct yet overlapping mechanisms, both of which are impaired in HIV infection.

Authors:  Sandra C Côté; Stephanie C Burke Schinkel; Tamara K Berthoud; Priscila O Barros; Maria Sanchez-Vidales; April M Davidson; Angela M Crawley; Jonathan B Angel
Journal:  Eur J Immunol       Date:  2020-05-27       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.